| Sacituzumab Govitecan +/- Pembrolizumab In HR+ / HER2 - MBC (NCT04448886) | Ana C Garrido-Castro, MD | 2020-09-23 |
| Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder Cancer (NCT03978624) | UNC Lineberger Comprehensive Cancer Center | 2020-09-23 |
| Open-Label Safety Study of AXS-05 in Subjects With TRD (EVOLVE) (NCT04634669) | Axsome Therapeutics, Inc. | 2020-09-23 |
| Efficacy and Safety Study of Nangibotide in Patients With COVID-19 Receiving Ventilatory Support (NCT04429334) | Inotrem | 2020-09-23 |
| Study of Efficacy, Safety and Tolerability of CMK389 in Patients With Chronic Pulmonary Sarcoidosis (NCT04064242) | Novartis Pharmaceuticals | 2020-09-23 |
| Clinical Trial of SBRT and Systemic Pembrolizumab With or Without Avelumab/Ipilimumab+ Dendritic Cells in Solid Tumors (NCT04571632) | Universitair Ziekenhuis Brussel | 2020-09-22 |
| Phase II Trial of Combination Immunotherapy in Subjects With Advanced Small Bowel and Colorectal Cancers (NCT04491955) | National Cancer Institute (NCI) | 2020-09-22 |
| The Impact on Hepatic Recurrence After Adjuvant Chemotherapy With Intraarterial Infusion of Idarubicin-Lipiodol (NCT04178642) | University Hospital, Montpellier | 2020-09-22 |
| Early Treatment of Language Impairment in Young Children With Autism Spectrum Disorder With Leucovorin Calcium (NCT04060017) | Southwest Autism Research & Resource Center | 2020-09-22 |
| Acalabrutinib in Combination With R-ICE For Relapsed or Refractory Lymphoma (NCT04189952) | University of Miami | 2020-09-22 |
| Radium-223 in Biochemically Recurrent Prostate Cancer (NCT04206319) | National Cancer Institute (NCI) | 2020-09-22 |
| Tacrolimus as Treatment of Breast Cancer-Related Lymphedema (NCT04541290) | Odense University Hospital | 2020-09-22 |
| Itacitinib for the Prevention of Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplantation (NCT04127721) | M.D. Anderson Cancer Center | 2020-09-22 |
| A Proof of Concept Study of Pradigastat in Patients With Functional Constipation (NCT04620161) | Anji Pharma | 2020-09-22 |
| Treatment of POEMS Syndrome With Daratumumab (NCT04396496) | University of Arkansas | 2020-09-22 |
| Subcutaneous Injections of ASC to Heal Digital Ulcers in Patients With Scleroderma. (NCT04356755) | University Hospital, Toulouse | 2020-09-22 |
| Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity (NCT04339777) | National Cancer Institute (NCI) | 2020-09-22 |
| Pragmatic Trial of Obsessive-compulsive Disorder (NCT04539951) | Shanghai Mental Health Center | 2020-09-22 |
| Efficacy of Adding Dexmedetomidine as an Adjuvant to Bupivacaine in TAP Block and Caudal Block (NCT04926454) | Ain Shams University | 2020-09-22 |
| Biomarker Analysis of Castration-resistant Prostate Cancer Undergoing Bipolar Androgen Therapy (NCT04424654) | Hospital Sirio-Libanes | 2020-09-22 |
| Treatment With Azacitidine of Recurrent Gliomas With IDH1/2 Mutation (NCT03666559) | Assistance Publique - Hôpitaux de Paris | 2020-09-22 |
| Jinhua Qinggan Granules in the Treatment of COVID-19 (NCT04723524) | University of Karachi | 2020-09-22 |
| Rapid Evaluation of Innovative Intervention Components to Maximize the Health Benefits of Behavioral Obesity Treatment Delivered Online: An Application of Multiphase Optimization Strategy (NCT04520256) | The Miriam Hospital | 2020-09-22 |
| Evaluation of Safety, Tolerability, and Efficacy of CordSTEM-DD in Patients With Chronic Low Back Pain (NCT04530071) | CHABiotech CO., Ltd | 2020-09-21 |
| PERUCONPLASMA: Evaluating the Use of Convalescent Plasma as Management of COVID-19 (NCT04497324) | Universidad Peruana Cayetano Heredia | 2020-09-21 |
| Metabolic Cofactor Supplementation and Hydroxychloroquine Combination in Covid-19 Patients (NCT04573153) | ScandiBio Therapeutics AB | 2020-09-21 |
| PLX2853 in Combination With Abiraterone Acetate and Prednisone and in Combination With Olaparib in Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (NCT04556617) | Opna Bio LLC | 2020-09-21 |
| Acamprosate Safe to Use in Individuals With Liver Disease. (NCT04287920) | Mayo Clinic | 2020-09-21 |
| A Dose-Confirmation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19 (NCT04515147) | CureVac | 2020-09-21 |
| Clinical Trial of Novel OPV2 Vaccine (NCT04693286) | International Centre for Diarrhoeal Disease Research, Bangladesh | 2020-09-21 |
| Convalescent Plasma as Adjunctive Therapy for Hospitalized Patients With COVID-19 (NCT04567173) | University of the Philippines | 2020-09-21 |
| DUR-928 in Subjects With SARS-CoV-2 With Acute Lung, Liver or Kidney Injury (NCT04447404) | Durect | 2020-09-21 |
| A Phase 2 Study Investigating the Effect of EDP1815 in the Treatment of Mild to Moderate Plaque Psoriasis (NCT04603027) | Evelo Biosciences, Inc. | 2020-09-21 |
| Lurbinectedin (PM01183) Combined With Pembrolizumab in Small Cell Lung Cancer. (NCT04358237) | Antonio Calles Blanco | 2020-09-21 |
| The Safety and Tolerability of Engensis (VM202) in Patients With Charcot-Marie-Tooth Disease Subtype 1A (CMT1A) (NCT05361031) | Helixmith Co., Ltd. | 2020-09-21 |
| Trial to Compare the Efficacy and Safety Of MW05 and PEG-rhG-CSF (NCT04554056) | Mabwell (Shanghai) Bioscience Co., Ltd. | 2020-09-21 |
| Effects of Probiotics (P. Pentosaceus, L. Lactis or L. Helveticus) in NASH (NCT04555434) | Chuncheon Sacred Heart Hospital | 2020-09-20 |
| QL1101 in Combination With JS001 in Patients With pMMR/MSS Refractory Metastatic Colorectal Cancer (NCT04527068) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2020-09-20 |
| Omega-3, Nigella Sativa, Indian Costus, Quinine, Anise Seed, Deglycyrrhizinated Licorice, Artemisinin, Febrifugine on Immunity of Patients With (COVID-19) (NCT04553705) | Beni-Suef University | 2020-09-20 |
| Efficacy and Safety of Dose-dense Chemotherapy (ddEC-ddP) for Neoadjuvant Chemotherapy of HER2-negative Breast Cancer (NCT04576143) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2020-09-20 |
| Safety, Tolerability, and Efficacy of Encaleret in Participants With Autosomal Dominant Hypocalcemia (ADH) Type 1 (NCT04581629) | Calcilytix Therapeutics, Inc., a BridgeBio company | 2020-09-20 |
| Atlas of Intracranial Recordings on Cortical Responses After Functional tACS (NCT04560959) | Xuanwu Hospital, Beijing | 2020-09-20 |
| Effect of TAP Block on Time Required for First Analgesic Dose After Cesarean Cection Under Spinal Anesthesia (NCT04623632) | Ain Shams Maternity Hospital | 2020-09-20 |
| Treatment of COVID-19 by Nebulization of Inteferon Beta 1b Efficiency and Safety Study (NCT04469491) | Centre Hospitalier Universitaire, Amiens | 2020-09-20 |
| Ivermectin Reproposing for Mild Stage COVID-19 Outpatients (NCT04784481) | Ministry of Public Health, Argentina | 2020-09-20 |
| COVIDIG (COVID-19 Hyper-ImmunoGlobulin) (NCT04555148) | Green Cross Corporation | 2020-09-19 |
| Reactogenicity, Safety and Immunogenicity of QazCovid-in® COVID-19 Vaccine (NCT04530357) | Research Institute for Biological Safety Problems | 2020-09-19 |
| Efficacy and Safety of Susu Zhike Granules for Treating Acute Cough Due to Common Cold With Cold-cough Syndrome in Children (NCT04457011) | Tasly Pharmaceutical Group Co., Ltd | 2020-09-19 |
| Testing of the Addition of a New Anti-cancer Drug, Molibresib, to Chemotherapy Treatment (Etoposide and Cisplatin) for Patients With NUT Carcinoma (NCT04116359) | National Cancer Institute (NCI) | 2020-09-18 |
| A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP, an Autoimmune Disorder That Affects the Peripheral Nerves) (NCT04280718) | argenx | 2020-09-18 |
| Dopaminergic restauratIon by intraVEntriculaire Administration (NCT04332276) | University Hospital, Lille | 2020-09-18 |
| Rifaximin for the Treatment of Gastrointestinal Toxicities Related to Pertuzumab-Based Therapy in Patients With Stage I-III HER2 Positive Breast Cancer (NCT04249622) | Mayo Clinic | 2020-09-18 |
| Use of Autologous Platelet-Rich Plasma to Treat Hypertrophic Burn Scars (NCT03935594) | Vanderbilt University Medical Center | 2020-09-18 |
| Galcanezumab for Vestibular Migraine (NCT04417361) | University of California, San Francisco | 2020-09-18 |
| Hydroxychloroquine for Treatment of Non-Severe COVID-19 (NCT04860284) | Makerere University | 2020-09-18 |
| AZD2811 and Durvalumab (MEDI4736) Combination Therapy in Relapsed Small Cell Lung Cancer (NCT04525391) | Se-Hoon Lee | 2020-09-18 |
| Study of Pembrolizumab and Ramucirumab in Pts With Progressive TCC After Treatment With an Immune Checkpoint Inhibitor (NCT04179110) | Yale University | 2020-09-18 |
| A Phase 1b Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SR419 (NCT04494815) | Shanghai SIMR Biotechnology Co., Ltd. | 2020-09-18 |
| A Study of sEphB4-HSA in Kaposi Sarcoma (NCT03993106) | Vasgene Therapeutics, Inc | 2020-09-17 |
| Study to Evaluate the Safety and Efficacy of High Dose Intravenous Immune Globulin (IVIG) Plus Standard Medical Treatment (SMT) Versus SMT Alone in Participants in Intensive Care Unit (ICU) With Coronavirus Disease (COVID-19) (NCT04480424) | Grifols Therapeutics LLC | 2020-09-17 |
| A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors (NCT04370587) | ImmVira Pharma Co. Ltd | 2020-09-17 |
| Safety and Efficacy of Etravirine in Friedreich Ataxia Patients (NCT04273165) | IRCCS Eugenio Medea | 2020-09-17 |
| A Phase 2 Study Evaluating the Safety and Efficacy of Netarsudil Ophthalmic Solution in Patients With Corneal Edema Due to Fuchs Corneal Dystrophy (NCT04498169) | Aerie Pharmaceuticals | 2020-09-17 |
| Study of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma (NHL) (NCT04533581) | Kyowa Kirin Co., Ltd. | 2020-09-17 |
| Study of an Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers (NCT04491877) | Sanofi Pasteur, a Sanofi Company | 2020-09-17 |
| Study to Assess the Efficacy and Safety of MEDI3506 in Adults With Uncontrolled Moderate-to-severe Asthma (NCT04570657) | AstraZeneca | 2020-09-17 |
| Phenytoin Cream for the Treatment of Neuropathic Pain (NCT04647877) | David J. Kopsky | 2020-09-17 |
| A Study of Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma (NCT04557098) | Janssen Research & Development, LLC | 2020-09-17 |
| A Study of JNJ-73763989 + Nucleos(t)Ide Analog in Participants Co-Infected With Hepatitis B and Hepatitis D Virus (NCT04535544) | Janssen Research & Development, LLC | 2020-09-17 |
| Abaloparatide and Pelvic Fracture Healing (NCT04249232) | Hospital for Special Surgery, New York | 2020-09-17 |
| Nivolumab Plus Metformin in Metastatic Renal Cell Carcinoma (NCT06884683) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2020-09-17 |
| FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma (NCT04625907) | University of Birmingham | 2020-09-17 |
| PF-07104091 as a Single Agent and in Combination Therapy (NCT04553133) | Pfizer | 2020-09-16 |
| Cyclophosphamide, Abatacept, and Tacrolimus for GvHD Prevention (NCT04503616) | NYU Langone Health | 2020-09-16 |
| COVID-19 Ozanimod Intervention Study (NCT04405102) | Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec | 2020-09-16 |
| Efficacy and Safety of SOX Regimen Combined With Camrelizumab as Neoadjuvant Treatment in Locally Advanced Gastric Cancer: a Phase II, Single-arm Study (NCT05602935) | The Second Affiliated Hospital of Fujian Medical University | 2020-09-16 |
| Chemo-Radiotherapy Boost Treatment Guided by Perfusion MRI on Hypoxic Zones in Head and Neck Cancer (NCT06880289) | Regina Elena Cancer Institute | 2020-09-16 |
| CPI-613 in Combination With Bendamustine in Patients With Relapsed/Refractory T-Cell Non-Hodgkin Lymphoma (NCT04217317) | Wake Forest University Health Sciences | 2020-09-16 |
| Study in COvid-19 Patients With iveRmectin (CORVETTE-01) (NCT04703205) | Kitasato University | 2020-09-16 |
| Study of OST-122 in Patients With Moderate to Severe Ulcerative Colitis (NCT04353791) | Oncostellae S.L | 2020-09-16 |
| Exenatide Once-weekly as a Treatment for Multiple System Atrophy (NCT04431713) | University College, London | 2020-09-16 |
| Targeting Reactive Oxygen Species Production as a Novel Therapeutic in Fuch's Endothelial Corneal Dystrophy (NCT04440280) | Massachusetts Eye and Ear Infirmary | 2020-09-16 |
| Study of Benralizumab in People With Skin Side Effects Caused by Cancer Therapies (NCT04552288) | Memorial Sloan Kettering Cancer Center | 2020-09-16 |
| Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC (NCT04140526) | OncoC4, Inc. | 2020-09-16 |
| Clinical Study to Evaluate the Treatment Effect and Safety of BAY1817080 in Patients With Overactive Bladder (OAB) (NCT04545580) | Bayer | 2020-09-16 |
| Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors (NCT04469530) | Emory University | 2020-09-16 |
| Phase 2 Study of KH903 in Patients With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma As Second-Line Therapy (NCT04555304) | Chengdu Kanghong Biotech Co., Ltd. | 2020-09-15 |
| Daily Vitamin D for Sickle-cell Respiratory Complications (NCT04170348) | Columbia University | 2020-09-15 |
| HIV-1 Infected Patients, Phase II Trial, Dual Combination Doravirine/Raltegravir Open Label (NCT04513626) | Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida | 2020-09-15 |
| Clinical Study of Liposomal Mitoxantrone Hydrochloride Injection Combined With Pegaspargase in the Treatment of NKTCL (NCT04509466) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2020-09-15 |
| A Study of Guselkumab in Participants With Active Lupus Nephritis (NCT04376827) | Janssen Research & Development, LLC | 2020-09-15 |
| Double-blind, Randomized, Controlled Clinical Trial to Assess Efficacy of MSC in Patients With COVID-19 ARDS (NCT04615429) | Cristina Avendaño Solá | 2020-09-15 |
| VentaProst in Subjects With COVID-19 Requiring Mechanical Ventilation (NCT04452669) | Aerogen Pharma Limited | 2020-09-15 |
| Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study (NCT04316117) | ECOG-ACRIN Cancer Research Group | 2020-09-15 |
| InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection ( ILIAD-7-US-I ) (NCT04442178) | Revimmune | 2020-09-15 |
| Camrelizumab With Apatinib as Neoadjuvant Therapy for Participants With Resectable Non-Small Cell Lung Cancer (NCT04506242) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2020-09-15 |
| Tislelizumab Combined With Pemetrexed/ Carboplatin in Patients With Brain Metastases of Non-squamous NSCLC (NCT04507217) | Sun Yat-sen University | 2020-09-15 |
| Bladder Instillations Versus Onabotulinumtoxin A for Treatment of Interstitial Cystitis/Bladder Pain Syndrome (NCT04401176) | Walter Reed National Military Medical Center | 2020-09-15 |
| Letermovir for the Prevention of Cytomegalovirus Reactivation in Patients With Hematological Malignancies Treated With Alemtuzumab (NCT04312841) | Ohio State University Comprehensive Cancer Center | 2020-09-15 |
| Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers (NCT04430738) | Seagen, a wholly owned subsidiary of Pfizer | 2020-09-15 |